Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Oct 27:e255465.
doi: 10.1001/jamainternmed.2025.5465. Online ahead of print.

Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants

Affiliations

Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants

Yi Du et al. JAMA Intern Med. .
No abstract available

Plain language summary

This observational study assesses the durability of protection provided by updated COVID-19 vaccines over a 7-month period, during which circulating SARS-CoV-2 variants were predominantly JN.1 descendants.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Comment in

  • doi: 10.1001/jamainternmed.2025.5462

References

    1. FDA approves and authorizes updated mRNA COVID-19 vaccines to better protect against currently circulating variants. Press release. US Food and Drug Administration. Published August 22, 2024. Accessed September 25, 2025. https://www.fda.gov/news-events/press-announcements/fda-approves-and-aut...
    1. FDA authorizes updated Novavax COVID-19 vaccine to better protect against currently circulating variants. Press release. US Food and Drug Administration. Published August 30, 2024. Accessed September 25, 2025. https://www.fda.gov/news-events/press-announcements/fda-authorizes-updat...
    1. Lin DY, Du Y, Xu Y, Paritala S, Donahue M, Maloney P. Durability of XBB.1.5 vaccines against omicron subvariants. N Engl J Med. 2024;390(22):2124-2127. doi: 10.1056/NEJMc2402779 - DOI - PMC - PubMed

LinkOut - more resources